Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006:2006 Suppl:40470.
doi: 10.1155/IDOG/2006/40470.

Epidemiology and natural history of human papillomavirus infections in the female genital tract

Affiliations
Review

Epidemiology and natural history of human papillomavirus infections in the female genital tract

Kevin A Ault. Infect Dis Obstet Gynecol. 2006.

Abstract

Human papillomavirus (HPV) is the most common newly diagnosed sexually transmitted infection in the United States. Although the majority of sexually active adults will be infected with HPV at least once in their lives, it is sexually active women less than 25 years of age who consistently have the highest rates of infection. Besides youth and gender, common risk factors for HPV infection and clinical sequelae of infection include high number of sexual partners and coinfection with Chlamydia trachomatis or herpes simplex virus. Most HPV infections are cleared by the immune system and do not result in clinical complications. Clinical sequelae in cases of low-risk HPV infection consist of genital warts, and clinical manifestations of high-risk HPV infection include abnormal Pap test results, low-grade squamous intraepithelial lesions (LSIL), high-grade squamous intraepithelial lesions (HSIL), and cervical cancer. LSIL, HSIL, and cervical cancer carry significant morbidity and/or mortality; genital warts and abnormal Pap test results are often significant sources of psychosocial distress. Currently, there are neither effective means of preventing HPV transmission nor cures for clinical manifestations: infection can only be prevented via complete sexual abstinence, while treatment for clinical sequelae such as genital warts and cytologic abnormalities consists of removing the problematic cells and watching for recurrence; this method consumes significant health care resources and is costly. New prophylactic HPV vaccines promise to dramatically reduce the incidence of HPV infection, genital warts, and cytologic abnormalities.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cumulative rate of HPV infection among college-aged women who were virgins at baseline. Adapted from Winer et al [3].
Figure 2
Figure 2
Seroprevalence of HPV 16 by age and gender. Modified from Stone et al [6].
Figure 3
Figure 3
Cumulative risk of CIN 2/3 after infection with HPV 16 or 18, or other types. Adapted from Winer et al [20].

Similar articles

Cited by

References

    1. Centers for Disease Control and Prevention. Genital HPV Infection—CDC Fact Sheet. Centers for Disease Control and Prevention. 2004.
    1. Koutsky LA. Epidemiology of genital human papillomavirus infection. The American Journal of Medicine. 1997;102(5 suppl 1):3–8. - PubMed
    1. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. American Journal of Epidemiology. 2003;157(3):218–226. - PubMed
    1. Brown DR, Shew ML, Qadadri B, et al. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. The Journal of Infectious Diseases. 2005;191(2):182–192. - PMC - PubMed
    1. Marrazzo JM, Koutsky LA, Kiviat NB, Kuypers JM, Stine K. Papanicolaou test screening and prevalence of genital human papillomavirus among women who have sex with women. American Journal of Public Health. 2001;91(6):947–952. - PMC - PubMed

MeSH terms

Substances